In certain cases, the Agency should defer the initiation or completion of some or all of the measures contained in a paediatric investigation plan, with a view to ensuring that research is conducted only when safe and ethical and that the requirement for study data in the paediatric population does not block or delay the authorisation of medicinal products for other populations.
Recital 14, Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 Decembe…
In forcecited 1×
Judgment of the General Court (Third Chamber) of 14 December 2011. Nycomed Danmark ApS v European Medicines Agency (EMA).Decision
That is all the more so since Article 20(1) of Regulation No 1901/2006 provides, under certain conditions, for the possibility of deferring the initiation or completion of some or all of the measures contained in a paediatric investigation …
14 Dec 2011 · 62009TJ0052